•
Mar 31
Omega Healthcare Q1 2025 Earnings Report
Omega Healthcare reported strong growth in revenue, EPS, and net income in Q1 2025.
Key Takeaways
Omega Healthcare posted solid Q1 2025 results, with notable increases in revenue, net income, and AFFO. The company raised its full-year AFFO guidance, driven by $423M in YTD investments and stronger operator performance.
Omega Healthcare
Omega Healthcare
Omega Healthcare Revenue by Segment
Omega Healthcare Revenue by Geographic Location
Forward Guidance
Omega raised its 2025 AFFO guidance based on completed investments and expected continued performance from its operators.
Positive Outlook
- AFFO guidance raised to $2.95–$3.01 per share
- Strong operator coverage and improving occupancy
- Significant new investments totaling $423M YTD
- Genesis resumed full rent and interest payments
- April acquisitions expected to be funded with equity
Challenges Ahead
- Ongoing monitoring of Genesis financial health due to prior missed payments
- Dependence on successful rent collection and operator liquidity
- Some remaining exposure to operators under bankruptcy protection (LaVie)
- AFFO guidance excludes impact of future acquisitions or losses
- Potential macroeconomic risks, including rate changes and labor shortages